Zhenkui Pan

Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.

Zhenkui Pan, Feng Ye, Xuan Wu et al. · PubMed · 2015 · 140 citations · Full text

Medicine, Oncology, Pathology +17

Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence

Haoxin Peng, Xiangrong Wu, Ran Zhong et al. · Frontiers in Immunology · 2021 · 65 citations · Full text

Medicine, Immunology, Oncology +17

The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis

Hengrui Liang, Zhenkui Pan, Wei Wang et al. · Journal of Thoracic Disease · 2018 · 51 citations · Full text

Medicine, Oncology, Pharmacology +8

PD‐(L)1 inhibitors <i>vs</i>. chemotherapy <i>vs</i>. their combination in front‐line treatment for NSCLC: An indirect comparison

Hengrui Liang, Zhichao Liu, Xiuyu Cai et al. · International Journal of Cancer · 2019 · 39 citations

Medicine, Oncology, Pharmacology +14

The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures

Qihua He, Peiling Xin, Mingzhe Zhang et al. · Translational Lung Cancer Research · 2019 · 36 citations · Full text

Medicine, Molecular Medicine, Oncology +15